5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group study.
Guy
J T
JT
Southwest Oncology Group Statistical Center, Seattle.
Fleming
T
T
Pollock
T W
TW
Rivkin
S E
SE
Pugh
R P
RP
Saiers
H
H
Hynes
H E
HE
Boyd
J F
JF
D000230:Adenocarcinoma / Q000188:drug therapy*; D000380:Agranulocytosis / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014747:Vinblastine